CCM [Concord Medical Services] 6-K: (Original Filing)

[Concord Medical Announces the Signing of US$50 Million IFC Loan Agreement BEIJING, May 15, 2013 — Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China and the parent of Chang’an Hospital, today announced that the Company] [TABLE OF CONTENTS EX-99.1 TABLE OF CONTENTS CONCORD MEDICAL SERVICES HOLDINGS LIMITED]

By | 2016-03-13T09:43:02+00:00 May 15th, 2013|Categories: CCM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

ONP [Orient Paper] 10-Q: (Original Filing)

[] [I, Zhenyong Liu certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Orient Paper, Inc.; ss 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [I, Winston C. Yen, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Orient Paper, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Zhenyong Liu Chief Executive Officer EX-32.1 4 v344505_ex32-1.htm EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Winston C. Yen Chief Financial Officer (principal financial and accounting officer) EX-32.2 5 v344505_ex32-2.htm EX-32.2]

By | 2016-03-19T22:30:55+00:00 May 15th, 2013|Categories: Chinese Stocks, ONP, SEC Original|Tags: , , , , , |0 Comments
Read More

TPI [TIANYIN PHARMACEUTICAL] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x For the quarterly period ended March 31, 2013 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone number, x o x] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2013 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2013 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong James Jiayuan Tong Chief Financial Officer, Director]

By | 2016-03-27T18:24:29+00:00 May 15th, 2013|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments
Read More

GRO [AGRIA] 6-K: Agria Subsidiary, PGG Wrightson, Updates Earnings Guidance BEIJING,

[Agria Subsidiary, PGG Wrightson, Updates Earnings Guidance BEIJING, May 14, 2013 - Agria Corporation (NYSE: GRO) (the Company or Agria) today announced that its New Zealand-listed subsidiary, PGG Wrightson Limited (PGW.NZ) (PGW), has provided an earnings guidance update. Earnings before interest, tax and depreciation (EBITDA) for the financial year ending June 30, 2013 is forecast]

By | 2016-01-10T05:13:19+00:00 May 15th, 2013|Categories: Chinese Stocks, GRO, Webplus ver|Tags: , , , , , |0 Comments
Read More

CCM [Concord Medical Services] 6-K: Concord Medical Announces the Signing of US$50 Million

[Concord Medical Announces the Signing of US$50 Million IFC Loan Agreement BEIJING, May 15, 2013 — Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China and the parent of Chang’an Hospital, today announced that the Company] [TABLE OF CONTENTS EX-99.1 TABLE OF CONTENTS CONCORD MEDICAL SERVICES HOLDINGS LIMITED]

By | 2016-03-13T09:45:05+00:00 May 15th, 2013|Categories: CCM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

ONP [Orient Paper] 10-Q:

[] [I, Zhenyong Liu certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Orient Paper, Inc.; ss 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [I, Winston C. Yen, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Orient Paper, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Zhenyong Liu Chief Executive Officer EX-32.1 4 v344505_ex32-1.htm EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Winston C. Yen Chief Financial Officer (principal financial and accounting officer) EX-32.2 5 v344505_ex32-2.htm EX-32.2]

By | 2016-03-19T22:31:44+00:00 May 15th, 2013|Categories: Chinese Stocks, ONP, Webplus ver|Tags: , , , , , |0 Comments
Read More

TPI [TIANYIN PHARMACEUTICAL] 10-Q: FORM 10-Q (Mark One) x For the quarterly

[FORM 10-Q (Mark One) x For the quarterly period ended March 31, 2013 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone number, x o x] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2013 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2013 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong James Jiayuan Tong Chief Financial Officer, Director]

By | 2016-03-27T18:25:31+00:00 May 15th, 2013|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Read More

CBPO [China Biologic Products] SC 13D/A: (Original Filing)

[JOINT FILING AGREEMENT Dated: May 15, 2013 WP X Biologics LLC Scott A. Arenare Attorney-in-Fact* WARBURG PINCUS PRIVATE EQUITY X, L.P.] [REGISTRATION RIGHTS AGREEMENT Agreement Company Purchaser This Registration Rights Agreement (this “ RECITALS Selling Stockholder Purchase Agreement Shares Common Stock The Company and the Purchaser hereby agree as follows: Definitions 1. 2009 Holders “ 2010 Holders “ Advice “ Affiliate “ Agreement “ Business Day “ Company “ Commission “ Common Stock “ Effectiveness Date “ Effectiveness Period “ Exchange] [ESCROW AGREEMENT WP X Biologics LLC Ms. Lin Ling Li WHEREAS, NOW THEREFORE 1. Appointment The Parties hereby appoint the Escrow Agent as their escrow agent for the purposes set forth herein, and the Escrow Agent hereby accepts such appointment under the terms and conditions set forth herein. 2. Escrow Document 2.1 Party B agrees to deposit with the Escrow] [AGREEMENT Agreement WP X Ms. Li Mr. Lin Parties Party This AGREEMENT (this “ WHEREAS Share Purchase Agreement WHEREAS Escrow Agreement Escrow Agent WHEREAS NOW, THEREFORE 1. Definitions 2. Delivery of Release Notice (a) HK Lawsuit Resolution Plaintiffs (b) Within ten (10) Business Days of the HK Lawsuit Resolution, the Parties shall deliver the Release Notice to the Escrow Agent] [CUSIP No. 16938C106 2 1. Names of reporting persons.]

By | 2016-04-03T00:26:57+00:00 May 15th, 2013|Categories: CBPO, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

AMCF [Andatee China Marine Fuel Services] 10-Q: (Original Filing)

[] [CERTIFICATION I, An Fengbin, certify that: 1. I have reviewed this Form 10-Q of Andatee China Marine Fuel Service Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Wang Hao, certify that: 1. I have reviewed this Form 10-Q of Andatee China Marine Fuel Service Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. An Fengbin President, Chief Executive Officer] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Wang Hao Chief Financial Officer]

By | 2016-03-13T18:53:59+00:00 May 15th, 2013|Categories: AMCF, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More
Skip to toolbar